Safety and Efficacy of FURESTEM-AD Inj. for Moderate to Severe Atopic Dermatitis (AD)
Clinical trial NCT05004324 · UNKNOWN
Trial details
- NCT number
- NCT05004324
- Sponsor
- Kang Stem Biotech Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-29
- Primary completion
- 2023-01-01
- Enrollment
- 308
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.